421 related articles for article (PubMed ID: 8264233)
1. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
[TBL] [Abstract][Full Text] [Related]
2. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy.
Roccatello D; Picciotto G; Ropolo R; Coppo R; Quattrocchio G; Cacace G; Molino A; Amoroso A; Baccega M; Isidoro C
Lab Invest; 1992 Jan; 66(1):86-95. PubMed ID: 1731150
[TBL] [Abstract][Full Text] [Related]
5. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
6. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
[TBL] [Abstract][Full Text] [Related]
7. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of IgA nephropathy.
Feehally J; Allen AC
Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
[TBL] [Abstract][Full Text] [Related]
9. Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy.
Rifai A; Schena FP; Montinaro V; Mele M; D'Addabbo A; Nitti L; Pezzullo JC
Lab Invest; 1989 Oct; 61(4):381-8. PubMed ID: 2796287
[TBL] [Abstract][Full Text] [Related]
10. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
11. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
13. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
Barratt J; Smith AC; Feehally J
Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
[TBL] [Abstract][Full Text] [Related]
14. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
15. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
16. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
17. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
Ding JX; Xu LX; Lv JC; Zhao MH; Zhang H; Wang HY
Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
[TBL] [Abstract][Full Text] [Related]
18. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
19. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
[TBL] [Abstract][Full Text] [Related]
20. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]